Protagonist Therapeutics (PTGX)

• Market cap: $5.71B
• 1 day: 3.18%
• 5 days: 6.17%
• 1 month: 9.79%
• 3 months: 58.26%
• 6 months: 62.11%
• Year to date: 134.43%
• 1 year: 119.66%
• 5 years: 323.84%
• 10 years: 681.03%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Employees: 128